Treatment Differences in Chronic Heart Failure Patients With Reduced Ejection Fraction According to Blood Pressure

Autor: Jesse F. Veenis, Hans-Peter Brunner-La Rocca, Marco W.F. van Gent, Gerard C.M. Linssen, Arno W. Hoes, Jasper J. Brugts
Přispěvatelé: Cardiology, Cardiologie, MUMC+: MA Med Staf Spec Cardiologie (9), RS: Carim - H02 Cardiomyopathy
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Zdroj: Circulation-Heart Failure, 13(5). Lippincott Williams & Wilkins
Circulation-Heart Failure, 13(5):006667. LIPPINCOTT WILLIAMS & WILKINS
ISSN: 1941-3289
Popis: Background: Prescribed dosages of heart failure (HF) therapy in patients with a reduced left ventricular ejection fraction remain lower than guideline recommended. It remains unclear whether systolic blood pressure (BP) influences prescription of HF drugs to HF patients with a reduced left ventricular ejection fraction in a European setting. This study aimed to investigate the role of systolic BP on the prescription rate and actual dose of guideline-recommended HF therapy. Methods: A total of 8246 patients with chronic HF with a reduced left ventricular ejection fraction from 34 Dutch outpatient HF clinics were included. Detailed information on prescription rates and dosages of HF drugs were assessed according to systolic BP categories ( Results: Patients with systolic BP P P for all trends, P for all trends, Conclusions: In this large cross-sectional cohort of patients with reduced left ventricular ejection fraction, patients with lower systolic BP receive more HF drugs but at lower dose relative to the target dose recommended in HF guidelines. Discussion is warranted regarding what target BP is acceptable and what should be limiting factors in uptitration to adequate levels of HF medication.
Databáze: OpenAIRE